OpenVSafe by OpenVAERS
Search V-safe

WAP-14789-30976

2 vaccinations 1 coded response 11 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
46-50
ZIP prefix
852 / AZ
Registered
2021-01-29
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-29
    Registered in v-safe
  2. 2021-01-29
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-29
    Health check-in — day 0, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  4. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  7. 2021-02-20
    Dose 2 — Pfizer-BioNTech
  8. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains
    Adult check-in
  10. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-03-06
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-03-13
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-24
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-08-22
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Cough, Injection site pain, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Aching at the injection site, coughing, sneezing, loss of taste
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  15. 2021-08-22
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  16. 2021-12-13

Vaccinations

DoseDateManufacturerCo-administered
12021-01-29Pfizer-BioNTech
22021-02-20Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-08-22 Unsuccessful

Free text

Release 9 — 6 months, dose 2

2021-08-22

Symptoms: Aching at the injection site, coughing, sneezing, loss of taste

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia ✓ · ✓
SDCough ✓ · ✓
SDInjection site pain ✓ · ✓
SDSneezing ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release